Pluristem Therapeutics Eyeing Daily Highs

Shares of Pluristem Therapeutics PSTI are trading higher on the session by 8.71%, at $3.62. The stock has been garnering bull support as of late and broke out of a key long-term range this morning, touching a high of $3.66. While Pluristem Therapeutics did give back some of those initial gains, shares have been battling back all day and are eyeing the daily high. A breech above that level could send shares rocketing higher. There is no firm historical resistance until $4.00-4.30. Note that Pluristem Therapeutics has a 1.39% short interest. The float is only a paltry 37.1 million shares, though. Pluristem Therapeutics Inc. is a bio-therapeutics company engaged in the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders